Philip Alex

Dr. Alex, M.D. Ph.D., is the co-founder and Chief Medical Officer of Haus Bioceuticals. Dr. Alex is expert in identifying inflammatory disease mechanisms using a combined laboratory and clinical research approach. His pioneering studies unlocked key insights and novel therapies for inflammatory diseases like rheumatoid arthritis, Crohn’s disease and ulcerative colitis. Dr. Alex’s rigorous R&D experience helped shape Haus’ culture. His focus on defining key inflammatory mechanisms provides a bridge between the world of natural and traditional medicine.